Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Cancer Therapy Market Growth in 2025?

The market size of cancer therapy has witnessed significant expansion recently. A rise from $190.44 billion in 2024 to $210.44 billion in 2025 with a compound annual growth rate (CAGR) of 10.5% is anticipated. Factors contributing to this growth in the historic period include an increase in global cancer incidents, a surge in the usage of chemotherapy procedures, greater consciousness about early detection of cancer, a growing number of oncology professionals, and enhanced access to treatments at hospitals.

What Is the Forecast for the Cancer Therapy Market Size Through 2029?

The market size for cancer therapy is projected to experience accelerated expansion in the years to come, reaching a value of $310.85 billion by 2029 with a compound annual growth rate (CAGR) of 10.2%. The predicted rise during the forecast period can be associated with an increasing requirement for personalized cancer treatments, amplified emphasis on outpatient cancer treatment, a surge in the acceptance of immunotherapy, more accessible healthcare in emerging economies, and an uptick in cancers related to lifestyle. Key trends for the forecast period comprise technological breakthroughs in cancer diagnostics, advancements in targeted drug delivery, investment in the research and development of biologics, the progression of AI-based treatment planning, and innovations in minimally invasive cancer surgeries.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

What are the Key Market Players in Cancer Therapy Market and How They’re Evolving?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

What Are the Primary Growth Drivers in the Cancer Therapy Market?

The growth of the cancer therapy market is anticipated to be spurred by the escalating rates of cancer worldwide. Cancer, defined as a collection of diseases marked by the rampant growth and proliferation of irregular cells in the organism, is predominantly attributed to heightened exposure to environmental carcinogens, including pollution and tobacco smoke. The critical function of cancer therapy is to manage the escalating instances of cancer by treating those affected, enhancing survival rates and minimizing disease advancement. For instance, the Switzerland-based intergovernmental body, the World Health Organization (WHO), predicted that by 2050, the global cancer incidence is anticipated to surpass 35 million new cases. This number represents a dramatic 77% increase from the projected 20 million cases in 2022. Consequently, the surging instances of cancer are fuelling the expansion of the cancer therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24492&type=smp

What Are the Leading Segments in the Global Cancer Therapy Industry?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegment:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

What Are the Key Market Trends in the Cancer Therapy Industry?

Leading businesses in the cancer therapy market are focusing their efforts on the development of innovative treatments, such as immuno-oncology medications, with the aim of enhancing the effectiveness of cancer treatment. These medications work by leveraging the power of the body’s immune system to identify and eliminate cancerous cells. Immuno-oncology drugs promote the immune system’s ability to target and eliminate cancer cells more efficiently. In December 2024, an immuno-oncology drug named Toripalimab was launched in India by Dr. Reddy’s Laboratories Ltd., a well-known Indian pharmaceutical firm. Toripalimab, the first and only medication of its kind authorized to treat nasopharyngeal cancer, offers a new, focused treatment option for those fighting this rare and aggressive type of cancer. By engaging the immune system, it could potentially enhance patient outcomes. The launch of toripalimab in India highlights Dr. Reddy’s dedication to increase the availability of advanced cancer treatments in regions that lack such services.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

What Is the Regional Outlook for the Cancer Therapy Market?

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24492

This Report Delivers Insight On:

1. How big is the cancer therapy market, and how is it changing globally?

2. Who are the major companies in the cancer therapy market, and how are they performing?

3. What are the key opportunities and risks in the cancer therapy market right now?

4. Which products or customer segments are growing the most in the cancer therapy market?

5. What factors are helping or slowing down the growth of the cancer therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model